Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: April 30, 2017

DrugPatentWatch Database Preview

Pioglitazone hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic sources for pioglitazone hydrochloride and what is the scope of pioglitazone hydrochloride patent protection?

Pioglitazone hydrochloride
is the generic ingredient in two branded drugs marketed by Mylan Pharms Inc, Teva Pharms Usa, Lupin Ltd, Accord Hlthcare, Zydus Pharms Usa Inc, Macleods Pharms Ltd, Aurobindo Pharma Ltd, Sandoz, Breckenridge Pharm, Takeda Pharms Usa, Dr Reddys Labs Ltd, Torrent Pharms Ltd, and Watson Labs, and is included in thirteen NDAs. There are two patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Pioglitazone hydrochloride has seventy-one patent family members in twenty-five countries.

There are twenty-seven drug master file entries for pioglitazone hydrochloride. Thirty-five suppliers are listed for this compound. There are two tentative approvals for this compound.

Summary for Generic Name: pioglitazone hydrochloride

Drug Master File Entries: see list27
Suppliers / Packagers: see list35
Bulk Api Vendors: see list82
Clinical Trials: see list1,112
Patent Applications: see list3,255
Therapeutic Class:Blood Glucose Regulators
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:pioglitazone hydrochloride at DailyMed


Applicant Application No. Form Dosage
► Subscribe► SubscribeTABLET; ORAL15MG
► Subscribe► SubscribeTABLET; ORAL30MG
► Subscribe► SubscribeTABLET; ORAL45MG
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
pioglitazone hydrochloride
TABLET;ORAL078670-002Feb 13, 2013ABRXNoNo► Subscribe► Subscribe
pioglitazone hydrochloride
TABLET;ORAL078670-001Feb 13, 2013ABRXNoNo► Subscribe► Subscribe
Lupin Ltd
pioglitazone hydrochloride
TABLET;ORAL204133-002Apr 7, 2014ABRXNoNo► Subscribe► Subscribe
Teva Pharms Usa
pioglitazone hydrochloride
TABLET;ORAL077210-003Jan 10, 2014ABRXNoNo► Subscribe► Subscribe
Teva Pharms Usa
pioglitazone hydrochloride
TABLET;ORAL077210-001Jan 10, 2014ABRXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Find generic sources and suppliers
  • Uncover prior art in abandoned patent applications and expired patents
  • Set up watchlists for daily email updates

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:

Google Plus